Calcitonin Gene-Related Peptide (CGRP) is a 37-amino acid peptide produced by peripheral and central neurons. It is found in a variety of organs and systems, regulating important functions in the target tissues. The αCGRP isoform is present in sensory neurons and it has been suggested to play a role in preventing hypertension, pulmonary hypertension, and ultimately acting as a potent vasodilator, improving blood flow distribution and wound healing. Studies have shown that exercise increases the levels of CGRP in skeletal and cardiac muscle cells. Studies in our laboratory suggest that CGRP may increase neurotrophic factor production by cultured cardiac cells (HL-1) in a dose depend manner, especially Glial Cell Line-Derived Neurotrophic Factor (GDNF). Finally, additional studies in our laboratory suggest that CGRP may reduce contraction rate of cultured Hl-1 cells. PURPOSE: To determine the effect of CGRP on heart contractility in frogs. METHODS: 12 frogs were divided into 4 groups. Three treatment groups received different concentrations of CGRP (40nMol, 100nMol, and 400nMol) in frog ringer’s solution. A control group was treated with only frog ringer’s solution. All frogs underwent autopsies to expose their hearts and each heart was connected to a PowerLab data acquisition system, which for collection of electrocardiogram, force of contraction, and heart rate using LabChart software. One-way ANOVA with Tukey post hoc were performed to determine statistical significance. RESULTS: Our results show that CGRP decreases force of contraction in all treatment groups when compared to the control group (Control: +9.20%; 40nM of GGRP: -38.35%; 100nM of CGRP: -34.29%; 400nM of CGRP: -33.10%; P<0.05). In addition, only 400nM of CGRP could, significantly, reduce the heart rate (Control: +3.32%; 400nM of CGRP: -24.01%; P<0.05). Finally, treatment with CGRP did not alter ECG (PQRST) curves in any of the treatment groups. CONCLUSIONS: Treatment with CGRP reduces force of contraction (in all treated groups) and reduces heart rate (400nM) without altering the ECG in frogs.